Investors are going to need a little more patience to see an investment in Stryker (SYK) come to fruition. While this diversified med-tech player is actually seeing some solid improvements in its business, 2012 is going to be a year of re-trenching. With a new CEO on the way and some potentially interesting developments in product development, Stryker is still a name to stick with in the healthcare sector.
Please click here for more:
Stryker's Business Healthier Than The Stock
No comments:
Post a Comment